Search Results - Andrew E Simor
- Showing 1 - 19 results of 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A Caenorhabditis elegans Host Model Correlates with Invasive Disease Caused by Staphylococcus aureus Recovered during an Outbreak in Neonatal Intensive Care by Kaiyu Wu, Andrew E Simor, Mary Vearncombe, Jo-Ann McClure, Kunyan Zhang
Published in Canadian Journal of Infectious Diseases and Medical Microbiology (2012-01-01)Get full text
Article -
11
Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects by George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, the Canadian Carbapenem Discussion Group
Published in Canadian Journal of Infectious Diseases (1998-01-01)Get full text
Article -
12
-
13
Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics by Kevin R Forward, Patricia A Franks, Donald E Low, Robert Rennie, Andrew E Simor, the Canadian Piperacillin/Tazobactam Study Group
Published in Canadian Journal of Infectious Diseases (1998-01-01)Get full text
Article -
14
Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital by Daniel B Gregson, Anne G Matlow, Andrew E Simor, Peter G Tuffnell, Donald E Low, Ronald Feld, James E Brunton
Published in Canadian Journal of Infectious Diseases (1992-01-01)Get full text
Article -
15
Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method by Abdul H Chagla, John H Hii, Daryl J Hoban, Andrew E Simor, Santiago Ferro, Evelyn Witwicki, Ruby Poon, Donald E Low
Published in Canadian Journal of Infectious Diseases (1992-01-01)Get full text
Article -
16
Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates by Kevin R Forward, Donald E Low, Michel Laverdiere, Robert Rennie, Andrew E Simor, Patricia A Franks, Members of the Canadian Piperacillin/Tazobactam Study Group
Published in Canadian Journal of Infectious Diseases (1997-01-01)Get full text
Article -
17
Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study by Nick Daneman, Nisha Andany, Jerome A Leis, Linor Berezin, Alice Zhabokritsky, Adrienne K Chan, Jose Estrada-Codecido, Andrea Gershon, Philip W Lam, Scott MacPhee, Andrew E Simor
Published in BMJ Open (2021-03-01)Get full text
Article -
18
Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Persistent or Recurrent Bacteremia by Henry Wong, Christine Watt, Sameer Elsayed, Michael John, Glen Johnson, Kevin Katz, Sigmund Krajden, Christine Lee, Tony Mazzulli, Krystyna Ostrowska, David Richardson, Baldwin Toye, Christie Vermeiren, Deborah Yamamura, Andrew E Simor
Published in Canadian Journal of Infectious Diseases and Medical Microbiology (2014-01-01)Get full text
Article -
19
External validation of clinical prediction rules for complications and mortality following Clostridioides difficile infection. by Catherine Beauregard-Paultre, Claire Nour Abou Chakra, Allison McGeer, Annie-Claude Labbé, Andrew E Simor, Wayne Gold, Matthew P Muller, Jeff Powis, Kevin Katz, Suzanne M Cadarette, Jacques Pépin, Louis Valiquette
Published in PLoS ONE (2019-01-01)Get full text
Article
